Drugs / Soy Supplement
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00255125 | Sep 2005 → Apr 2009 | prostate neoplasm | VA Office of Research and Development | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Soy Supplement | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00255125 ↗ |
| Route | Oral | “Patient will receive 4 capsules twice a day (8 capsules) daily to be taken with water or juice (except grapefruit juice).” NCT00255125 ↗ |